<code id='67AD54835C'></code><style id='67AD54835C'></style>
    • <acronym id='67AD54835C'></acronym>
      <center id='67AD54835C'><center id='67AD54835C'><tfoot id='67AD54835C'></tfoot></center><abbr id='67AD54835C'><dir id='67AD54835C'><tfoot id='67AD54835C'></tfoot><noframes id='67AD54835C'>

    • <optgroup id='67AD54835C'><strike id='67AD54835C'><sup id='67AD54835C'></sup></strike><code id='67AD54835C'></code></optgroup>
        1. <b id='67AD54835C'><label id='67AD54835C'><select id='67AD54835C'><dt id='67AD54835C'><span id='67AD54835C'></span></dt></select></label></b><u id='67AD54835C'></u>
          <i id='67AD54835C'><strike id='67AD54835C'><tt id='67AD54835C'><pre id='67AD54835C'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:Wikipedia    Page View:5
          Optum
          Mark Lennihan/AP

          UnitedHealth Group and Optum are getting rid of the name of their tech-driven care management company just months after the company faced congressional criticism over the use of its algorithms to cut off payments for patients’ care.

          Discontinuing the NaviHealth name is part of a broader rebranding of Optum’s division that provides services to people at home and in post-acute facilities. The move also encapsulates how UnitedHealth is pushing to control every piece of patient care outside of the hospital and distancing itself from the aspects that have generated controversy.

          advertisement

          Starting in the first quarter of 2024, Optum’s post-acute-care companies will be called Home & Community Care, according to internal documents obtained by STAT. However, Optum advised employees that “Home & Community Care should not be directly next to the Optum logo” in marketing materials.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          I was wrong about Geron's blood cancer drug. Now, is it a takeover target?
          I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

          MollyFerguson/STATIwaswrongaboutGeron.Foryears,I’vebelieved—anddeclaredpublicly—thatGeron’sefforttod

          read more
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more

          U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

          JOSEPHPREZIOSO/AFPviaGettyImagesLONDON—TheU.K.’scost-effectivenesswatchdogsaidThursdayitisnotyetreco